ATE100438T1 - Phenethanolaminderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. - Google Patents

Phenethanolaminderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.

Info

Publication number
ATE100438T1
ATE100438T1 AT90304327T AT90304327T ATE100438T1 AT E100438 T1 ATE100438 T1 AT E100438T1 AT 90304327 T AT90304327 T AT 90304327T AT 90304327 T AT90304327 T AT 90304327T AT E100438 T1 ATE100438 T1 AT E100438T1
Authority
AT
Austria
Prior art keywords
group
proviso
compounds
carbon atoms
sum total
Prior art date
Application number
AT90304327T
Other languages
English (en)
Inventor
Ian Frederick Skidmore
Lawrence Henry Charles C Lunts
Harry Finch
Alan Naylor
Ian Baxter Campbell
Charles Willbe
William Leonard Mitchell
Stephen Swanson
Brian David Judkins
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE100438T1 publication Critical patent/ATE100438T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/31—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/35—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT90304327T 1989-04-24 1990-04-23 Phenethanolaminderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. ATE100438T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898909273A GB8909273D0 (en) 1989-04-24 1989-04-24 Chemical compounds
EP90304327A EP0401966B1 (de) 1989-04-24 1990-04-23 Phenethanolaminderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
ATE100438T1 true ATE100438T1 (de) 1994-02-15

Family

ID=10655605

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90304327T ATE100438T1 (de) 1989-04-24 1990-04-23 Phenethanolaminderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.

Country Status (11)

Country Link
US (1) US5066678A (de)
EP (1) EP0401966B1 (de)
JP (1) JPH0372448A (de)
AT (1) ATE100438T1 (de)
AU (1) AU631865B2 (de)
CA (1) CA2015188A1 (de)
DE (1) DE69006107T2 (de)
GB (1) GB8909273D0 (de)
NZ (1) NZ233414A (de)
PT (1) PT93844A (de)
ZA (1) ZA903049B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
US5775329A (en) * 1995-06-07 1998-07-07 Gensia, Inc. Method and compounds for diagnosing coronary artery disease
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
ATE381537T1 (de) * 2001-03-22 2008-01-15 Glaxo Group Ltd Formanilid-derivative als beta2-adrenorezeptor- agonisten
ES2438985T3 (es) * 2001-09-14 2014-01-21 Glaxo Group Limited Formulación de inhalación que comprende derivados de fenetanolamina para el tratamiento de enfermedades respiratorias
GB0217225D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicinal compounds
GB0303396D0 (en) * 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2900415A (en) * 1954-12-14 1959-08-18 Lakeside Lab Inc Synthesized antispasmodic compounds
FR148F (de) * 1962-01-24
DE1618005A1 (de) * 1966-09-22 1971-09-09 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
GB1214012A (en) * 1967-12-21 1970-11-25 Allen & Hanburys Ltd Phenylethanolamines
ATE1899T1 (de) * 1979-06-16 1982-12-15 Beecham Group Plc Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
US4404222A (en) * 1980-08-25 1983-09-13 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and improving the efficiency of feed utilization thereby
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
CH665632A5 (fr) * 1984-07-13 1988-05-31 Glaxo Group Ltd Composes d'aminophenol.
GB8426191D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
EP0223410A3 (de) * 1985-10-16 1987-11-19 Glaxo Group Limited Ethanolaminderivate
US4959381A (en) * 1987-02-10 1990-09-25 Glaxo Group Limited Pyridine compounds which have useful activity associated with reversible air ways obstruction
EP0286242A3 (de) * 1987-03-12 1989-08-09 Glaxo Group Limited Ethanolamin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Verbindungen
DE3714484A1 (de) * 1987-04-30 1988-11-10 Bayer Ag Neue aminophenylethylamin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als leistungsfoerderer

Also Published As

Publication number Publication date
ZA903049B (en) 1991-05-29
AU631865B2 (en) 1992-12-10
JPH0372448A (ja) 1991-03-27
NZ233414A (en) 1992-09-25
CA2015188A1 (en) 1990-10-24
AU5377790A (en) 1990-10-25
EP0401966B1 (de) 1994-01-19
GB8909273D0 (en) 1989-06-07
US5066678A (en) 1991-11-19
DE69006107T2 (de) 1994-05-05
DE69006107D1 (de) 1994-03-03
PT93844A (pt) 1990-11-20
EP0401966A1 (de) 1990-12-12

Similar Documents

Publication Publication Date Title
FR2669336B1 (fr) Nouveaux derives d'oxazolo pyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
DE3584120D1 (de) Tetrapyrrolverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE113284T1 (de) Purinverbindungen, verfahren zu ihrer herstellung und pharmazeutische präparate.
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
GR3024956T3 (en) Substituted (5,6)-dihydronaphthalenyl compounds having retinoid-like activity.
KR970704710A (ko) 트리아졸 화합물 및 도파민 D₃리간드로서의 그의 용도(Triazole Compounds and Their Use as Dopamine-D₃-Ligands)
ATE89547T1 (de) Dopamin-vorlaeufer.
CA2015475A1 (en) Treating agent for osteoarthritis
IE883400L (en) Phenethanolamine derivatives
EP0398720A3 (de) Piperazin-Derivate
AU631865B2 (en) Phenethanolamine derivatives, processes for their preparation and pharmaceutical compositions containing them
HU900656D0 (en) Process for producing anti-phlogistic aryl compounds
ATE109470T1 (de) Phenylpyridon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES8308833A1 (es) "un metodo para la preparacion de 3-fenil-1-indanaminas".
ZA803031B (en) Paromomycin derivatives
FR2691149B1 (fr) Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
GR3006606T3 (de)
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
DE69307071D1 (de) Kardioaktive 17B-aryl und 17B-heterozyklyl-5-beta,14-beta-Androstan-Derivate,ein Verfahren zu ihrer Herstellung und pharmazeutische Phäparate davon
ATE178797T1 (de) Neue morphinzusammensetzungen für iontophoretische verabreichung
FR2707982B1 (fr) Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ATE101119T1 (de) Butensaeure-amide, deren salze, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
ATE46510T1 (de) Ergolinderivate, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und verwendung.
TH13528A (th) ซัลโฟแนมิโด-และซัลโฟมิโดคาร์บอนิลพิริดีน-2-?คาร์บอกแซมีดและพิริดีน-n-ออกไซด์ของสาร?เหล่านั้น, กรรมวิธีสำหรับเตรียมสารเหล่านั้นและ?การใช้สารเหล่านั้นเป็นยา
FR2691967B1 (fr) Nouveaux composes pyrrolothienopyraziniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee